Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Standard

Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial. / Pedersen, Anne Marie Lynge; Asmussen, Karsten; Holm, Lars Morten; Reibel, Jesper; Jacobsen, Søren.

2011.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Harvard

Pedersen, AML, Asmussen, K, Holm, LM, Reibel, J & Jacobsen, S 2011, 'Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial'.

APA

Pedersen, A. M. L., Asmussen, K., Holm, L. M., Reibel, J., & Jacobsen, S. (2011). Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial.

Vancouver

Pedersen AML, Asmussen K, Holm LM, Reibel J, Jacobsen S. Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial. 2011.

Author

Pedersen, Anne Marie Lynge ; Asmussen, Karsten ; Holm, Lars Morten ; Reibel, Jesper ; Jacobsen, Søren. / Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial.

Bibtex

@conference{48acff1333514ae5bf03451996b54ffd,
title = "Rituximab may induce true disease modification in primary Sj{\"o}gren{\textquoteright}s syndrome – an open trial",
author = "Pedersen, {Anne Marie Lynge} and Karsten Asmussen and Holm, {Lars Morten} and Jesper Reibel and S{\o}ren Jacobsen",
year = "2011",
month = sep,
language = "English",

}

RIS

TY - ABST

T1 - Rituximab may induce true disease modification in primary Sjögren’s syndrome – an open trial

AU - Pedersen, Anne Marie Lynge

AU - Asmussen, Karsten

AU - Holm, Lars Morten

AU - Reibel, Jesper

AU - Jacobsen, Søren

PY - 2011/9

Y1 - 2011/9

M3 - Conference abstract for conference

ER -

ID: 38420824